Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)
CNY 8.16
(0.25%)
CNY 8.16
(0.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.02 Billion CNY | 8.15% |
| 2022 | 921.94 Million CNY | 25.85% |
| 2021 | 403.49 Million CNY | 42.5% |
| 2020 | 483.18 Million CNY | 12.04% |
| 2019 | 249.43 Million CNY | 16.41% |
| 2018 | 366.11 Million CNY | 2.49% |
| 2017 | 392.88 Million CNY | 37.59% |
| 2016 | 283.61 Million CNY | 51.46% |
| 2015 | 184.59 Million CNY | 20.79% |
| 2014 | 151.26 Million CNY | 25.56% |
| 2013 | 122 Million CNY | 22.64% |
| 2012 | 99.56 Million CNY | 11.01% |
| 2011 | 88.89 Million CNY | 20.51% |
| 2010 | 73.56 Million CNY | 21.51% |
| 2009 | 61.39 Million CNY | 24.04% |
| 2008 | 49.66 Million CNY | 29.06% |
| 2007 | 38.78 Million CNY | 14.09% |
| 2006 | 31.45 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 244.17 Million CNY | -7.68% |
| 2024 Q1 | 253 Million CNY | 52.81% |
| 2024 Q3 | 206.9 Million CNY | -23.82% |
| 2023 Q4 | 166.41 Million CNY | -45.05% |
| 2023 FY | - CNY | 8.15% |
| 2023 Q2 | 248.67 Million CNY | 12.36% |
| 2023 Q1 | 221.31 Million CNY | 37.3% |
| 2023 Q3 | 302.85 Million CNY | 21.79% |
| 2022 Q2 | 211.84 Million CNY | 1.98% |
| 2022 Q3 | 265.22 Million CNY | 25.2% |
| 2022 FY | - CNY | 25.85% |
| 2022 Q1 | 207.73 Million CNY | 27.85% |
| 2022 Q4 | 161.19 Million CNY | -39.23% |
| 2021 Q3 | 210.06 Million CNY | 56.55% |
| 2021 Q1 | 153.33 Million CNY | 53.53% |
| 2021 FY | - CNY | 42.5% |
| 2021 Q4 | 162.48 Million CNY | -22.65% |
| 2021 Q2 | 134.18 Million CNY | -12.49% |
| 2020 Q4 | 99.87 Million CNY | -38.73% |
| 2020 FY | - CNY | 12.04% |
| 2020 Q3 | 163 Million CNY | 69.68% |
| 2020 Q2 | 96.06 Million CNY | -0.19% |
| 2020 Q1 | 96.25 Million CNY | -5.84% |
| 2019 Q2 | 93.52 Million CNY | 17.15% |
| 2019 FY | - CNY | 16.41% |
| 2019 Q4 | 102.22 Million CNY | -18.83% |
| 2019 Q3 | 125.93 Million CNY | 34.65% |
| 2019 Q1 | 79.83 Million CNY | 24.76% |
| 2018 FY | - CNY | 2.49% |
| 2018 Q1 | 76.85 Million CNY | -34.54% |
| 2018 Q4 | 63.99 Million CNY | -47.38% |
| 2018 Q2 | 80.12 Million CNY | 4.25% |
| 2018 Q3 | 121.61 Million CNY | 51.79% |
| 2017 Q4 | 117.42 Million CNY | 20.35% |
| 2017 FY | - CNY | 37.59% |
| 2017 Q1 | 54.28 Million CNY | -29.0% |
| 2017 Q2 | 82.38 Million CNY | 51.76% |
| 2017 Q3 | 97.56 Million CNY | 18.42% |
| 2016 FY | - CNY | 51.46% |
| 2016 Q2 | 58.94 Million CNY | 38.96% |
| 2016 Q1 | 42.41 Million CNY | 41.61% |
| 2016 Q3 | 65.96 Million CNY | 11.91% |
| 2016 Q4 | 76.46 Million CNY | 15.92% |
| 2015 Q1 | 27.1 Million CNY | -27.18% |
| 2015 Q3 | 57.25 Million CNY | 26.07% |
| 2015 Q2 | 45.41 Million CNY | 67.56% |
| 2015 FY | - CNY | 20.79% |
| 2015 Q4 | 29.95 Million CNY | -47.68% |
| 2014 Q2 | 30.81 Million CNY | 39.36% |
| 2014 FY | - CNY | 25.56% |
| 2014 Q4 | 37.21 Million CNY | -9.44% |
| 2014 Q1 | 22.11 Million CNY | -31.67% |
| 2014 Q3 | 41.09 Million CNY | 33.35% |
| 2013 Q4 | 32.36 Million CNY | -3.56% |
| 2013 FY | - CNY | 22.64% |
| 2013 Q1 | 15.98 Million CNY | -52.39% |
| 2013 Q2 | 26.65 Million CNY | 66.77% |
| 2013 Q3 | 33.55 Million CNY | 25.93% |
| 2012 Q2 | 19.13 Million CNY | 147.03% |
| 2012 Q4 | 33.56 Million CNY | 27.0% |
| 2012 FY | - CNY | 11.01% |
| 2012 Q3 | 26.43 Million CNY | 38.12% |
| 2012 Q1 | 7.74 Million CNY | -76.57% |
| 2011 Q2 | 26.73 Million CNY | 260.99% |
| 2011 FY | - CNY | 20.51% |
| 2011 Q4 | 33.05 Million CNY | 57.37% |
| 2011 Q3 | 21 Million CNY | -21.42% |
| 2011 Q1 | 7.4 Million CNY | -59.44% |
| 2010 FY | - CNY | 21.51% |
| 2010 Q4 | 18.26 Million CNY | 5.24% |
| 2010 Q1 | 8.78 Million CNY | -21.86% |
| 2010 Q3 | 17.35 Million CNY | -13.42% |
| 2010 Q2 | 20.03 Million CNY | 127.98% |
| 2009 Q4 | 11.24 Million CNY | -35.93% |
| 2009 Q2 | 16.53 Million CNY | 65.1% |
| 2009 Q3 | 17.55 Million CNY | 6.15% |
| 2009 Q1 | 10.01 Million CNY | 8.74% |
| 2009 FY | - CNY | 24.04% |
| 2008 Q4 | 9.21 Million CNY | -2.24% |
| 2008 FY | - CNY | 29.06% |
| 2008 Q3 | 9.42 Million CNY | 0.0% |
| 2007 FY | - CNY | 14.09% |
| 2006 FY | - CNY | 0.0% |